MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Country |
 USA |
IPO year |
2005 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
390 M |
Market Cap[1] |
$ 23.9 B |
EBITDA (LTM) |
$ 1 B |
P/E (LTM) |
37.45 |
P/S (LTM) |
5.31 |
EPS (LTM) |
1.59 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
$ 17.1 | 0.56 % | $ 181 M | Nasdaq Global Market |  China |
 |
CareDx, Inc
CDNA
|
$ 21.5 | 3.32 % | $ 1.15 B | Nasdaq Global Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 114.52 | -0.86 % | $ 34.8 B | NYSE,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 1.55 | - | $ 2.06 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.81 | 1.31 % | $ 689 M | Nasdaq Global Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 14.13 | -6.98 % | $ 427 M | Nasdaq Global Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 112.85 | -4.63 % | $ 9.31 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 135.78 | 7.13 % | $ 21.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 85.5 | 1.04 % | $ 5.77 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Myriad Genetics
MYGN
|
$ 4.8 | 1.05 % | $ 444 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 9.44 | 1.94 % | $ 1.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 417.54 | -0.27 % | $ 12 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.41 | 5.77 % | $ 390 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 165.78 | -0.71 % | $ 8.22 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.16 | -0.87 % | $ 20 B | NYSE |  Niderland |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Guardant Health
GH
|
$ 87.6 | 0.6 % | $ 11 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 5.78 | 4.71 % | $ 342 M | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Interpace Biosciences
IDXG
|
$ 2.12 | 7.07 % | $ 9.38 M | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 5.1 | -22.84 % | $ 213 M | NYSE American | USA |
 |
Soleno Therapeutics
SLNO
|
$ 52.87 | 0.09 % | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 469.21 | -2.04 % | $ 177 B | NYSE,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 60.4 | 3.34 % | $ 3.61 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.19 | 0.46 % | $ 5.03 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 255.84 | -0.37 % | $ 21.3 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 125.65 | 3.54 % | $ 5.88 B | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 207.28 | 0.54 % | $ 20.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.53 | 1.38 % | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Waters Corporation
WAT
|
$ 307.12 | -0.68 % | $ 18.3 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 192.67 | -0.79 % | $ 21.4 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.